Establishment of CRISPR/Cas9 Genome-Editing System Based on Dual sgRNAs in .

J Fungi (Basel)

Key Laboratory of Microbiological Engineering of Agricultural Environment, Ministry of Agriculture, Department of Microbiology, College of Life Sciences, Nanjing Agricultural University, Nanjing 210095, China.

Published: June 2022

AI Article Synopsis

  • The text discusses the use of CRISPR/Cas9 technology for precision genome editing of a commercially important edible fungus, previously referred to as "Asian."
  • The authors successfully developed a genome-editing system using plasmids containing codon-optimized Cas9 and dual sgRNAs, resulting in mutants that show resistance to 5-fluorooric acid (5-FOA).
  • The study identified a native U6 promoter and demonstrated heritable genomic changes in the mutants, marking the first successful CRISPR/Cas9 application in this type of fungus, thus expanding its potential for molecular breeding.

Article Abstract

, previously known as Asian , is one of the most commercially important edible fungi, with nutritional value and medicinal properties worldwide. However, precision genome editing using CRISPR/Cas9, which is a revolutionary technology and provides a powerful tool for molecular breeding, has not been established in . Here, plasmids harboring expression cassettes of Basidiomycete codon-optimized Cas9 and dual sgRNAs targeting under the control of the promoter and FfU6 promoter, respectively, were delivered into protoplasts of Dan3 strain through PEG-mediated transformation. The results showed that an efficient native U6 promoter of was identified, and ultimately several mutants exhibiting 5-fluorooric acid (5-FOA) resistance were obtained. Additionally, diagnostic PCR followed by Sanger sequencing revealed that fragment deletion between the two sgRNA target sites or small insertions and deletions (indels) were introduced in these mutants through the nonhomologous end joining (NHEJ) pathway, resulting in heritable changes in genomic information. Taken together, this is the first report in which a successful CRISPR/Cas9 genome-editing system based on dual sgRNAs was established in , which broadens the application of this advanced tool in Basidiomycetes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318071PMC
http://dx.doi.org/10.3390/jof8070693DOI Listing

Publication Analysis

Top Keywords

dual sgrnas
12
crispr/cas9 genome-editing
8
genome-editing system
8
system based
8
based dual
8
establishment crispr/cas9
4
sgrnas asian
4
asian commercially
4
commercially edible
4
edible fungi
4

Similar Publications

Coronaviruses utilize a positive-sense single-strand RNA, functioning simultaneously as mRNA and the genome. An RNA-dependent RNA polymerase (RdRP) plays a dual role in transcribing genes and replicating the genome, making RdRP a critical target in therapies against coronaviruses. This review explores recent advancements in understanding the coronavirus transcription machinery, discusses it within virus infection context, and incorporates kinetic considerations on RdRP activity.

View Article and Find Full Text PDF

Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells.

Cell Stem Cell

December 2024

Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Harvard Stem Cell Institute, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

Gene editing the BCL11A erythroid enhancer is a validated approach to fetal hemoglobin (HbF) induction for β-hemoglobinopathy therapy, though heterogeneity in edit allele distribution and HbF response may impact its safety and efficacy. Here, we compare combined CRISPR-Cas9 editing of the BCL11A +58 and +55 enhancers with leading gene modification approaches under clinical investigation. Dual targeting of the BCL11A +58 and +55 enhancers with 3xNLS-SpCas9 and two single guide RNAs (sgRNAs) resulted in superior HbF induction, including in sickle cell disease (SCD) patient xenografts, attributable to simultaneous disruption of core half E-box/GATA motifs at both enhancers.

View Article and Find Full Text PDF

Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing.

Eur J Pharm Sci

December 2024

Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität Munich, Butenandtstrasse 5-13, 81377 Munich, Germany; Center for Nanoscience (CeNS), LMU Munich, 80799 Munich, Germany; CNATM - Cluster for Nucleic Acid Therapeutics Munich, Germany. Electronic address:

Article Synopsis
  • CRISPR/Cas9 technology is a promising method for treating genetic diseases, but its effectiveness is limited by the availability of suitable delivery systems for the Cas9/sgRNA ribonucleoprotein (RNP).
  • This study explores dual pH-responsive amphiphilic xenopeptides (XPs) for delivering CRISPR/Cas9 RNP, demonstrating successful cellular uptake and genome editing in various cell lines, including a model for Duchenne muscular dystrophy (DMD).
  • Notably, modified xenopeptides increased gene editing efficiency, with some achieving an EC50 value as low as 0.51 nM, indicating improved potential for therapeutic applications.
View Article and Find Full Text PDF

Generation of Ext1 Gene-Edited Mice Model Via Dual sgRNAs/Cas9 System and Phenotypic Analyses.

Mol Biotechnol

November 2024

Key Laboratory of Medical Biotechnology and Translational Medicine (Guilin Medical University), Education Department of Guangxi Zhuang Autonomous Region, School of Intelligent Medicine and Biotechnology, Guilin Medical University, Guilin, 541199, China.

Hereditary multiple exostoses (HME) is an autosomal dominant skeletal disease. Genetic linkage analyses have identified that mutations in the exostosin glycosyltransferase (EXT)1 and EXT2 genes are linked to HME pathogenesis, with EXT1 mutation being the most frequent. The aim of this study was to generate a mice model with Ext1 gene editing to simulate human EXT1 mutation and investigate the genetic pathogenicity of Ext1 through phenotypic analyses.

View Article and Find Full Text PDF
Article Synopsis
  • Traditional overexpression techniques struggle to accurately analyze protein-protein interactions and expression in B lymphocytes due to their resistance to lipid transfection.
  • The article discusses advanced CRISPR/Cas9 knock-in methods that increase efficiency in tagging endogenous proteins, along with protocols for optimizing cutting efficiency and sgRNA selection.
  • Detailed methodologies for engineering B lymphoma cells are provided, including assessing editing efficiency, designing repair templates, electroporation, and selecting engineered cells, enabling broader application in other cell types.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!